Govt Job for Ph.D, M.Pharm as Research Associate at Centre of Bio Medical Research

Centre of Bio-Medical Research (CBMR) is committed to build a world class research institute dedicated to disease-oriented-research and to translate discoveries and observations of the laboratory into new diagnosis and therapies for the benefit of humanity.

Research at CBMR emphasizes the creation of (basic) knowledge in the chemical and biosciences for its application in diagnosis and therapies, the pursuit of fundamental scientific advances through interdisciplinary programs and collaborations, and the education and training of researchers preparing to meet the biomedical challenges of the future.

Post :Research Associate (RA)

Project Title : Chemoenzymatic, Asymmetric, Total Synthesis of Nodulones and Their Non-Natural Analogs using a Fungal Oxidoreductase Enzyme and its Biosynthetic Implications

Principal Investigator : Dr. Syed Masood Husain
Funding Agency : CSIR HRDG Extramural Division

Fellowship : As per CSIR Research Scheme Guidelines, fellowship with Ph.D. will be Rs. 47,000/ per month + HRA as per rule. The post is purely temporary and co-terminus with the project subject to the condition that the same may be terminated earlier on one month notice of either side.

The fellowship amount will be determined based on the educational qualification and experiences.

Duration :  Initially one year (Extendable upto 3 years based on performance)

Essential Qualification : Ph.D. in Chemistry / Biochemistry or equivalent OR having 3 years of research, teaching and design development experience in MPharma

Desirable Qualification : Experience in multistep organic synthesis with interdisciplinary research experience and good publication record will be preferred.

Age Upper age limit : 35 Years (Age relaxation as per CSIR rules)

Application Instruction
Candidates are requested to appear online for an interview on July 27, 2021. Interested eligible persons must send their application with cover letter, CV with name of two references and their list of publications on or before July 24 , 2021 to the following email address

academic.cell@cbmr.res.in

Informal inquiries on project detail can be directed to the PI: Dr. Syed Masood Husain at smhusain@cbmr.res.in

Date & Time of Interview :July 27, 2021 at 11:00 AM

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore